Kobi Nathan

Kobi Nathan is an Associate Professor in the Department of Pharmacy Practice and Administration at St. John Fisher University's Wegmans School of Pharmacy, providing clinical pharmacy services and precepting pharmacy students at Monroe Community Hospital—a county-operated long-term care facility. As a board-certified geriatric pharmacotherapy specialist, he serves on an interprofessional Geriatric Assessment Team diagnosing dementia and advising primary care providers for vulnerable elderly patients.

His educational credentials include a Pharm.D. from St. John Fisher University, complemented by an M.Ed. and B.A. from the University of Arkansas-Fayetteville. Following post-graduate residency training at SUNY Upstate Medical University, he joined his alma mater's faculty in 2013 after nine years in higher education administration.

Dr. Nathan's research centers on geriatric pharmacotherapy, with emphases on deprescribing interventions, pharmacokinetics/pharmacodynamics in aging populations, and neurological disorder therapeutics (Parkinson's, dementia). He concurrently investigates andragogical learning models in pharmacy education, analyzing how adult learners engage with professional curricula. His clinical specialty involves rehabilitation unit pharmacotherapy for stroke, traumatic brain/spinal cord injury, and congenital deformity cases.

Publication analysis reveals consistent focus on medication safety in home health and post-acute care settings, particularly deprescribing frameworks, antipsychotic use in dementia, and geriatric syndrome-hospitalization linkages. Key journals include Clinical Therapeutics and Journal of the American Geriatrics Society, often co-authored with interdisciplinary teams.

His professional recognitions include:

• Certified Geriatric Pharmacist
• Board Certified Geriatric Pharmacotherapy Specialist

Dr. Nathan mentors PharmD students during clinical rotations at Monroe Community Hospital, leveraging prior administrative experience to enhance curriculum development. While specific grant details aren't documented, his research scope implies external funding in geriatric pharmacotherapy. He actively contributes to community care through the Geriatric Assessment Team and long-term care facility services, addressing complex polypharmacy cases in aging populations.